2012
DOI: 10.1007/s00134-012-2695-9
|View full text |Cite
|
Sign up to set email alerts
|

Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

26
290
2
25

Year Published

2014
2014
2021
2021

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 363 publications
(343 citation statements)
references
References 36 publications
26
290
2
25
Order By: Relevance
“…About 85.2% of them used the antibiotics before blood specimen collection, which was much higher than the 20% reported by a multi-center study and included the 1100 ICU patients with nBSIs (Tabah et al, 2012). However, compared with that study, the most frequent use of antibiotics for treating BSIs was the same; they were carbapenems and glycopeptides.…”
Section: Discussionmentioning
confidence: 67%
See 1 more Smart Citation
“…About 85.2% of them used the antibiotics before blood specimen collection, which was much higher than the 20% reported by a multi-center study and included the 1100 ICU patients with nBSIs (Tabah et al, 2012). However, compared with that study, the most frequent use of antibiotics for treating BSIs was the same; they were carbapenems and glycopeptides.…”
Section: Discussionmentioning
confidence: 67%
“…However, appropriate empirical therapy can protect patients from mortality at 28 d. The mortality rate was reduced by approximately 4-fold in patients receiving appropriate empirical therapy compared to those without (OR=0.23, P=0.001). As shown in other studies, appropriate empirical antibiotic treatment has been known to be the most effective treatment for BSIs (Sogaard et al, 2011) and inappropriate empirical antibiotic therapy has been one of the most important risk factors for mortality in nBSIs (Tabah et al, 2012). Therefore, how to improve the empirical use of antibiotics in the early period of BSIs in order to reduce the 28-d mortality in our hospital should be elaborated in future studies.…”
Section: Discussionmentioning
confidence: 80%
“…41 Regarding Gram-negative organisms, the EURO-BACT study found that MDR Gram-negative pathogens play a role in more than half of cases in ICU. 27 BSIs due to ESBL-producing Enterobacteriacae represent a challenge for clinicians, due to the resistance of the organisms to third generation cephalosporins. The effectiveness of antibiotic regimens including b-lactam/b-lactamase inhibitors has not been demonstrated in randomized clinical trials, in particular in the subset of critically ill patients, and carbapenems are often used as the first choice.…”
Section: Antibiotic Resistancementioning
confidence: 99%
“…However, emergence of resistance to antimicrobials is challenging our practice by threatening to reverse decades of progress [2]. Patients with few or no effective antibiotic therapy options due to resistance are increasingly observed and the possibility exists that this will worsen to the point where in some countries or patient populations the antibiotic therapy era will become only of historical relevance over the next two decades [3]. Given the current situation, antibiotic resistance, especially among Gram-negative pathogens, will most likely continue to evolve with low-income countries at greatest risk [4].…”
mentioning
confidence: 99%